PT  - JOURNAL ARTICLE
AU  - Swarnali Sharma
AU  - Vitaly Volpert
AU  - Malay Banerjee
TI  - Extended SEIQR type model for COVID-19 epidemic and data analysis
AID  - 10.1101/2020.08.10.20171439
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.08.10.20171439
4099  - http://medrxiv.org/content/early/2020/08/12/2020.08.10.20171439.short
4100  - http://medrxiv.org/content/early/2020/08/12/2020.08.10.20171439.full
AB  - An extended SEIQR type model is considered in order to model the COVID-19 epidemic. It contains the classes of susceptible individuals, exposed, infected symptomatic and asymptomatic, quarantined, hospitalized and recovered. The basic reproduction number and the final size of epidemic are determined. The model is used to fit available data for some European countries. A more detailed model with two different subclasses of susceptible individuals is introduced in order to study the influence of social interaction on the disease progression. The coefficient of social interaction K characterizes the level of social contacts in comparison with complete lockdown (K = 0) and the absence of lockdown (K = 1). The fitting of data shows that the actual level of this coefficient in some European countries is about 0.1, characterizing a slow disease progression. A slight increase of this value in the autumn can lead to a strong epidemic burst.Competing Interest StatementThe authors have declared no competing interest.Funding StatementIncluded in the text.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not required.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe source of the data used in this manuscript are mentioned clearly. https://www.worldometers.info/coronavirus/